1. Oral propranolol as a new treatment for facial infantile hemangioma: case report.
- Author
-
Ferreira Rda C, Wolff FR, and Mörschbächer R
- Subjects
- Female, Humans, Induction Chemotherapy methods, Infant, Treatment Outcome, Adrenergic beta-Antagonists therapeutic use, Eyelid Neoplasms drug therapy, Hemangioma, Capillary drug therapy, Neoplastic Syndromes, Hereditary drug therapy, Propranolol therapeutic use
- Abstract
Hemangiomas are the most common benign tumors of infancy. Despite their self-limited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.
- Published
- 2011
- Full Text
- View/download PDF